The mechanisms demonstrated in this study DPC proliferation and anti-apoptosis are relevant to multiple types of hair loss, not just androgenetic alopecia
A., & Fisher, G
At a glance Drug / evolocumab (Repatha), a PCSK9-inhibitor biologic antibody Supplement / glutathione (oral, liposomal, or IV forms) Known interaction / none documented in published literature or FDA label Interaction type / not applicable, no shared metabolic pathway identified Evolocumab clearance / proteolytic catabolism, not CYP450 or GSH-dependent Glutathione CYP effect / negligible at typical oral doses (250 to 1,000 mg/day) LDL-C reduction with evolocumab / up to 59% vs
Other Ingredients: Glycerin, medium chain triglycerides, phospholipids (soy), natural flavor
I received my order quickly and the product is exactly as promised
Hydrochloric acid and/or sodium hydroxide may be used to adjust the pH